Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Stomach Neoplasms 1Peritoneal Neoplasms 1Neoplasms by Site 1Liver Neoplasms 1Liver Diseases 1Digestive System Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Irinotecan 4Gemcitabine 4130-nm albumin-bound paclitaxel 4napabucasin 3Cyclophosphamide 3Bevacizumab 3Albumin-Bound Paclitaxel 3selpercatinib 2pembrolizumab 2cobimetinib 2Sunitinib 2Sorafenib 2Pemetrexed 2Paclitaxel 2Leucovorin 2Fluorouracil 2Drug Therapy 2Chemoradiotherapy 2Cetuximab 2Aspirin 2Ascorbic Acid 2trametinib 1repotrectinib 1pralsetinib 1osimertinib 1lutetium Lu 177 dotatate 1linifanib 1guadecitabine 1golotimod 1genexol-PM 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × genexol-PM × Gastrointestinal × Clear all
NCT03008512 2021-02-04

A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib

Gachon University Gil Medical Center

Phase 2 Terminated
5 enrolled
Gastrointestinal

Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡